% Expired Patents = 40.0

Forward Citations = 10

Loading Chart...

3 inventors (with patents filed for the assignee):

Dennis J Thiele (5 out of 8 patents)

Daniel W Neef (5 out of 5 patents)

Jose Serafin Mendoza (5 out of 16 patents)

4. Jose S Mendoza (0 patent)

5 patents: Sort by Forward Citations

1. 9718784 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),

2. 9717709 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),

3. 9447058 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2016-09-20),

4. 9315449 - Substituted pyrazoles as heat shock transcription factor activators (2016-04-19),

5. 9156775 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2015-10-13),

Company Overview

Chaperone Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. With a strong emphasis on chaperone-mediated protein folding, the company aims to target protein misfolding and aggregation in order to treat conditions such as Alzheimer's and Parkinson's disease. By harnessing the power of chaperone proteins, Chaperone Therapeutics is dedicated to advancing novel treatment options for patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#120 in Durham, NC

#1,123 in North Carolina

#51,620 in US

Durham, NC, United States of America

Chaperone Therapeutics, Inc.

Forward Citations = 10

3 inventors:

Dennis J Thiele (5 out of 8 patents)

Daniel W Neef (5 out of 5 patents)

Jose Serafin Mendoza (5 out of 16 patents)

4. Jose S Mendoza (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chaperone Therapeutics, Inc.. Retrieved from https://idiyas.com/company/chaperone-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]